SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-041693
Filing Date
2017-08-09
Accepted
2017-08-09 16:18:27
Documents
41
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v472285_10q.htm 10-Q 337158
2 EXHIBIT 31.1 v472285_ex31-1.htm EX-31.1 9289
3 EXHIBIT 31.2 v472285_ex31-2.htm EX-31.2 9287
4 EXHIBIT 32.1 v472285_ex32-1.htm EX-32.1 3711
5 EXHIBIT 32.2 v472285_ex32-2.htm EX-32.2 3689
  Complete submission text file 0001144204-17-041693.txt   2067518

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20170630.xml EX-101.INS 323836
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20170630.xsd EX-101.SCH 22541
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20170630_cal.xml EX-101.CAL 39825
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20170630_def.xml EX-101.DEF 144072
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20170630_lab.xml EX-101.LAB 185774
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20170630_pre.xml EX-101.PRE 162399
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 171018181
SIC: 2836 Biological Products, (No Diagnostic Substances)